Guggenheim Capital’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306K Buy
+6,593
New +$237K ﹤0.01% 1501
2026
Q1
– Sell
-19,781
Closed -$491K – 1819
2025
Q4
$491K Buy
+19,781
New +$525K ﹤0.01% 1291

Other funds holding ASTH

Guggenheim Capital's ASTH Position: Q2 2026 in Review

Guggenheim Capital opened a new position in Astrana Health (ASTH) in Q2 2026: 6,593 shares worth $306K. The stake represents ﹤0.01% of the portfolio and ranks #1501 among its holdings. This is a return to the name: Guggenheim Capital previously reported a position in ASTH as recently as Q4 2025.

Guggenheim Capital first reported a position in ASTH in Q4 2025 and has held it in 2 quarters since. The position peaked at $491K in Q4 2025. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Guggenheim Capital held 6,593 shares of Astrana Health worth $306K as of Q2 2026.
  • Astrana Health was a new Guggenheim Capital position in Q2 2026.
  • Astrana Health made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1501 holding.
  • Guggenheim Capital first reported a position in Astrana Health in Q4 2025 and has held it in 2 quarters since.
  • Guggenheim Capital's Astrana Health position peaked at $491K in Q4 2025.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.